![]() |
Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital & Medical School, Dundee, DD1 9SY, Scotland, UK Phone: +44 1382 Fax: +44 1382 e-mail to a.d.struthers@dundee.ac.uk |
![]() |
INVITED LECTURES |
(1982-2000) |
|
| Total of 120 lectures, selected ones are | ||
| Modulation of renal function by ACE inhibitors and atrial natriuretic factor. SKB Prize Lecture, British Pharmacological Society Meeting, London, 1991. Drug treatment in chronic heart failure - an overview. Royal College of Physicians of Edinburgh Symposium on Heart Failure, 1993. The treatment of heart failure in the 1990's. British Geriatrics Society Guest Lecture, London, 1993. Heart failure: detection and management. The MacFarlane Lecture, Perth Royal Infirmary, Perth, 1993. Health Care Delivery in Chronic Heart Failure. Chief Scientist Office Meeting on Heart Failure, Glasgow, 1994. Aldosterone Escape During ACE Inhibition Therapy. Heart Failure 95 Meeting of the European Society of Cardiology, Amsterdam 1995. Renin Inhibitors. Heart Failure 97, Cologne, 1997. The Renal Effects of ACE Inhibitors Heart Failure 97, Cologne, 1997. Clinical evidence for autonomic and profibrotic effects of aldosterone in heart failure. Heart Failure 97, Cologne, 1997. Peptides for diagnosing Heart Failure. British Society for Heart Failure, Manchester 1997. Harmful effects of Aldosterone despite ACE Inhibitors in Heart Failure Japanese College of Cardiology, Sapporo, Japan, 1997. Pharmacotherapy for Heart Failure SIGN Guidelines open meeting, Royal College of Physicians, Glasgow, 1997 Is aldosterone as much of a culprit as angiotensin II? Symposium: 100 years of the Renin Angiotensin System, Rome, Italy, 1998 The Vascular Renin Angiotensin System in Heart Failure Heart Failure 98, Glasgow, 1998 The Natural History of Heart Failure. British Heart Foundation workshop on the Epidemiology of Heart Failure. London, 1998. Inhibitors of the renin-angiotensin system, present and future Withering Bicentenary Symposium, Royal College of Physicians of Edinburgh, 1999 Cardiovascular effects of endoscopic surgery. European Association of Endoscopic Surgery, Linz, Austria, 1999 Is the renin angiotensin system suppressed by ACE inhibitors 2nd International Symposium on AII Antagonists, London The RALES Trial British Society of Heart Failure, Manchester 1998 The link between hypertension and heart failure Heart Failure 99, Goteberg, 1999 The Mechanisms of Cardiac Death. Scottish Society for Experimental Medicine Review Lecture, Dundee 1999. Novel ways to improve endothelial dysfunction in chronic heart failure. Symposium on "Endothelial Dysfunction: Who Cares?" At ASCEPT meeting, Sydney, Australia, 1999. Developing Drugs to treat the mechanisms contributing to Cardiac Death. BPS Invited Lecture at the Australian Society of Clinical and Experimental Pharmacology & Toxicology (ASCEPT), Sydney, Australia, 1999. Diagnostic and Prognosotic Uses of Cardiac Peptides. British Society for Heart Failure, Glasgow, 2000. Genomic versus non-genomic effects ofmineralosorticoids. European Society of Cardiology, Amsterdam, 2000. Update on Treatment of Heart failure and Post MI with AII Antagonist. Japanese College of Cardiology, Osaka, Japan, 2000. Diagnosis of Heart Failure. Royal College of Physicians of Glasgow, Heart Failure Symposium, 2000. Aldosterone: An old hormone with new harmful effects. 4th Annual meeting of Society for Cardiovascular Endocrinology, Palm Cove, Queensland, Australia, 2000. Reactivation of the Renin Angiotensin System in Heart Failure Grand Rounds at Columbia University, New York, 2000. Endothelial dysfunction improvement by spironolactone inCHF. French Society of Cardiology, Paris 2001. The Angiotensin-Aldosterone system in CHF. Cardiology update 2001, Davos, Switzerland, 2001. |
||
Page author -Julie Struthers
e-mail: j.struthers@abertay.ac.uk
Copyright © 2001 [Professor Allan
Struthers] All rights reserved.
Revised:10/03/01 .